Pharmafile Logo

Say Goodbye to Costly Delays – Origins’ Clinical Trial Participant Simulations Have the Answer!

Lack of Patient Involvement in Clinical Trial Designs Causes Major Issues
Low recruitment and retention of clinical trials is a key issue faced by many clinical trials. These can lead to protocol adjustments resulting in increasing costs, as well as delays to successfully bringing a product to market; to patients who need it.

The Power of Clinical Trial Participant Simulations
Clinical trial simulation involves testing specific key aspects of the recruitment and conduct of a clinical trial with patients in a risk-free environment. It provides the opportunity to identify potential barriers to participation and to optimise the design, prior to trial initiation; therefore, creating a more positive experience for patients. A range of areas can be explored in a clinical trial simulation, including:

- PMLiVE

- PMLiVE

Solutions
Avoid costly delays with Origins’ clinical trial participant simulation. Reach out at contact@origins-patients.com to request more information or book a meeting with us by clicking here.

This content was provided by Origins – The Patient Focused Specialists

Company Details

 Latest Content from  Origins – The Patient Focused Specialists 

Origins’ Knowledge Centre

A collection of resources including webinar recordings, publications and short videos to help you be more patient focussed

Origins Insights Offering Explained

Origins believe that the patient voice not only should but must be included at all stages of the product lifecycle, we believe the question is no longer about why, but...

Introduction to Origins

In this short video Mark Corbett, Chief Innovation Officer at Resonant Group, gives a brief introduction to Origins, the patient focused specialist agency.If you'd like to know more, visit the...

Origins’ Strategy Offering Explained

What do we mean when we say that at Origins, we provide patient focused strategies throughout the product lifecycle? In this short video Origins’ Director Su Smith explains our strategy...

End-to-end patient strategy: Making a treatment for patients, with patients

The integration of patient engagement in all stages of a product lifecycle is starting to become much more commonplace and you may start to hear the term end-to-end patient strategy...

ORIGINS cements its specialist position with a truly patient focused offering

Origins are the patient focused specialists that create and deliver strategy, insights, experience data and solutions across the product lifecycle

FREE WEBINAR: End-to-end patient strategy: making a treatment for patients, with patients

Origins announces the first speaker on the panel of our upcoming webinar

ORIGINS INSIGHTS EVOLVES INTO PATIENT SPECIALIST AGENCY

Deeper focus on patient engagement across the pharma/biotech product lifecycle

Mark Corbett explains why Origins is evolving

Resonant Group Chief Innovation Officer, Mark Corbett has released a video explain why Origins is evolving from a Patient Insights agency to a Patient Focused Specialist agency.

MIRANDA DINI APPOINTED CHIEF OPERATING OFFICER AT RESONANT GROUP

Two additional leadership moves also strengthen management team